162 related articles for article (PubMed ID: 20823291)
1. Diet-induced obesity accelerates acute lymphoblastic leukemia progression in two murine models.
Yun JP; Behan JW; Heisterkamp N; Butturini A; Klemm L; Ji L; Groffen J; Müschen M; Mittelman SD
Cancer Prev Res (Phila); 2010 Oct; 3(10):1259-64. PubMed ID: 20823291
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin correlates with obesity: A study of 159 childhood acute leukemia survivors from India.
Srivastava R; Batra A; Tyagi A; Dhawan D; Ramakrishnan L; Bakhshi S
Indian J Cancer; 2015; 52(2):195-7. PubMed ID: 26853401
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Bcr/Abl-positive acute lymphoblastic leukemia in P190 transgenic mice with the farnesyl transferase inhibitor SCH66336.
Reichert A; Heisterkamp N; Daley GQ; Groffen J
Blood; 2001 Mar; 97(5):1399-403. PubMed ID: 11222386
[TBL] [Abstract][Full Text] [Related]
4. Crk-associated substrate lymphocyte type regulates myeloid cell motility and suppresses the progression of leukemia induced by p210Bcr/Abl.
Seo S; Nakamoto T; Takeshita M; Lu J; Sato T; Suzuki T; Kamikubo Y; Ichikawa M; Noda M; Ogawa S; Honda H; Oda H; Kurokawa M
Cancer Sci; 2011 Dec; 102(12):2109-17. PubMed ID: 21848808
[TBL] [Abstract][Full Text] [Related]
5. Distinct phenotypes of obesity-prone AKR/J, DBA2J and C57BL/6J mice compared to control strains.
Alexander J; Chang GQ; Dourmashkin JT; Leibowitz SF
Int J Obes (Lond); 2006 Jan; 30(1):50-9. PubMed ID: 16231032
[TBL] [Abstract][Full Text] [Related]
6. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice.
Voncken JW; Kaartinen V; Pattengale PK; Germeraad WT; Groffen J; Heisterkamp N
Blood; 1995 Dec; 86(12):4603-11. PubMed ID: 8541551
[TBL] [Abstract][Full Text] [Related]
7. Incidence of obesity does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: role of leptin, insulin, and IGF-1.
Papadia C; Naves LA; Costa SS; Vaz JA; Domingues L; Casulari LA
Horm Res; 2007; 68(4):164-70. PubMed ID: 17356293
[TBL] [Abstract][Full Text] [Related]
8. High-fat Western diet-induced obesity contributes to increased tumor growth in mouse models of human colon cancer.
O'Neill AM; Burrington CM; Gillaspie EA; Lynch DT; Horsman MJ; Greene MW
Nutr Res; 2016 Dec; 36(12):1325-1334. PubMed ID: 27866828
[TBL] [Abstract][Full Text] [Related]
9. BCR/ABL rearrangement and leukemia phenotype.
Saglio G; Pane F; Martinelli G; Guerrasio A
Leukemia; 1999 Apr; 13 Suppl 1():S96. PubMed ID: 10232378
[No Abstract] [Full Text] [Related]
10. A farnesyltransferase inhibitor increases survival of mice with very advanced stage acute lymphoblastic leukemia/lymphoma caused by P190 Bcr/Abl.
Mishra S; Zhang B; Groffen J; Heisterkamp N
Leukemia; 2004 Jan; 18(1):23-8. PubMed ID: 14603339
[TBL] [Abstract][Full Text] [Related]
11. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges.
Tsilingiris D; Vallianou NG; Spyrou N; Kounatidis D; Christodoulatos GS; Karampela I; Dalamaga M
Curr Obes Rep; 2024 Mar; 13(1):1-34. PubMed ID: 38159164
[TBL] [Abstract][Full Text] [Related]
12. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
13. High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
Young FM; Campbell A; Emo KL; Jansson J; Wang PY; Jordan CT; Mullen CA
Biol Blood Marrow Transplant; 2008 Jun; 14(6):622-30. PubMed ID: 18489987
[TBL] [Abstract][Full Text] [Related]
14. Model mice for BCR/ABL-positive leukemias.
Honda H; Hirai H
Blood Cells Mol Dis; 2001; 27(1):265-78. PubMed ID: 11358387
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation.
Nicolini FE; Mauro MJ; Martinelli G; Kim DW; Soverini S; Müller MC; Hochhaus A; Cortes J; Chuah C; Dufva IH; Apperley JF; Yagasaki F; Pearson JD; Peter S; Sanz Rodriguez C; Preudhomme C; Giles F; Goldman JM; Zhou W
Blood; 2009 Dec; 114(26):5271-8. PubMed ID: 19843886
[TBL] [Abstract][Full Text] [Related]
16. Animal models for chronic myeloid leukemia and acute lymphoblastic leukemia.
Groffen J; Voncken JW; van Schaick H; Heisterkamp N
Leukemia; 1992; 6 Suppl 1():44-6. PubMed ID: 1548935
[No Abstract] [Full Text] [Related]
17. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias.
Honda H; Oda H; Suzuki T; Takahashi T; Witte ON; Ozawa K; Ishikawa T; Yazaki Y; Hirai H
Blood; 1998 Mar; 91(6):2067-75. PubMed ID: 9490692
[TBL] [Abstract][Full Text] [Related]
18. The effect of combined inositol supplementation on maternal metabolic profile in pregnancies complicated by metabolic syndrome and obesity.
Ferrari F; Facchinetti F; Ontiveros AE; Roberts RP; Saade MM; Blackwell SC; Sibai BM; Refuerzo JS; Longo M
Am J Obstet Gynecol; 2016 Oct; 215(4):503.e1-8. PubMed ID: 27255472
[TBL] [Abstract][Full Text] [Related]
19. Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis.
Koschmieder S; Göttgens B; Zhang P; Iwasaki-Arai J; Akashi K; Kutok JL; Dayaram T; Geary K; Green AR; Tenen DG; Huettner CS
Blood; 2005 Jan; 105(1):324-34. PubMed ID: 15331442
[TBL] [Abstract][Full Text] [Related]
20. [Clinical characteristics and outcomes of 59 patients with acute lymphoblastic leukemia positive for BCR/ABL].
Liu Z; Liu XL; Du QF; Xu N; Zhong M; Song LL; Yi ZS; Liu QF; Meng FY; Zhou SY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Mar; 29(3):512-5. PubMed ID: 19304540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
